Literature DB >> 26529930

[Bisphosphonate].

Hiroshi Hagino.   

Abstract

Bisphosphonates (BPs) are first-line drugs in the management of osteoporosis. BPs' significant efficacy in the prevention of vertebral, non-vertebral, and hip fractures has been proven. BPs are now available as an injection as well as as oral administration in Japan. This review gives an overview of the efficacy as well as the clinical issues of the bisphosphonates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26529930

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  1 in total

1.  Effectiveness of monthly intravenous ibandronate on the low responders to oral bisphosphonate: the MOVEMENT study.

Authors:  Hiroshi Hagino; Akinori Sakai; Satoshi Ikeda; Yasuo Imanishi; Hiroshi Tsurukami; Satoru Nakajo; Naohisa Miyakoshi
Journal:  J Bone Miner Metab       Date:  2019-05-16       Impact factor: 2.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.